tiprankstipranks
Advertisement
Advertisement
Morning News Wrap-Up 3/31/26: Today’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up 3/31/26: Today’s Biggest Stock Market Stories!
2d ago
Alkermes jumps 15% on renewed biotech M&A buzz, says Leerink
Premium
The Fly
Alkermes jumps 15% on renewed biotech M&A buzz, says Leerink
2d ago
Centessa acquisition ‘may help rouse’ Alkermes shares, says RBC Capital
Premium
The Fly
Centessa acquisition ‘may help rouse’ Alkermes shares, says RBC Capital
2d ago
Centessa rises 45.7%
PremiumThe FlyCentessa rises 45.7%
2d ago
Morning Movers: Marvell jumps following Nvidia investment, AI factory pact
Premium
The Fly
Morning Movers: Marvell jumps following Nvidia investment, AI factory pact
2d ago
Video: Deals in food and pharmaceuticals headline busy morning of M&A
Premium
The Fly
Video: Deals in food and pharmaceuticals headline busy morning of M&A
2d ago
Eli Lilly to acquire Centessa for $38.00 per share in cash plus one CVR
PremiumThe FlyEli Lilly to acquire Centessa for $38.00 per share in cash plus one CVR
2d ago
CNTA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CNTA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
9d ago
Centessa’s ORX750 Poised as Potential Best-in-Class Orexin Agonist with Upcoming Phase 2a Catalyst and Favorable Risk–Reward
Premium
Ratings
Centessa’s ORX750 Poised as Potential Best-in-Class Orexin Agonist with Upcoming Phase 2a Catalyst and Favorable Risk–Reward
14d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100